06996.HK
Antengene Corporation Limited
HKSE · Healthcare · Biotechnology · CN
HKD 3.31
+1.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.23x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.38x
- PEG TTM
- —
- Price / book
- 1.94x
- Price / sales
- 3.18x
- Price / cash flow
- -13.91x
Enterprise value
- Enterprise value
- HKD 1.5B
- EV / sales
- 2.27x
- EV / EBITDA
- 7.27x
- EV / EBIT
- 8.12x
- Market cap
- HKD 2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026